SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-676874
Filing Date
2016-08-09
Accepted
2016-08-09 16:52:54
Documents
3
Period of Report
2016-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d226880d8k.htm 8-K 14519
2 EX-99.1 d226880dex991.htm EX-99.1 53032
3 GRAPHIC g226880g0809225916389.jpg GRAPHIC 3098
  Complete submission text file 0001193125-16-676874.txt   73119
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 161818684
SIC: 2834 Pharmaceutical Preparations